Fulminant diabetes mellitus and concomitant enterovirus infection: a clinical case
- 作者: Saprina T.V.1, Musina N.N.1, Vtorushin S.V.1,2, Krakhmal’ N.V.1,2, Rogovskaya Y.V.3
-
隶属关系:
- Siberian State Medical University
- Cancer Research Institute, Tomsk National Research Medical Center
- Cardiology Research Institute, Tomsk National Research Medical Center
- 期: 卷 26, 编号 2 (2020)
- 页面: 125-132
- 栏目: Case reports
- ##submission.dateSubmitted##: 19.08.2020
- ##submission.datePublished##: 19.08.2020
- URL: https://medjrf.com/0869-2106/article/view/42556
- DOI: https://doi.org/10.18821/0869-2106-2020-26-2-125-132
- ID: 42556
如何引用文章
详细
Fulminant type 1 diabetes mellitus is a subtype of diabetes mellitus. It is characterized by the extremely rapid development of hyperglycemia and ketoacidosis because of the near-total destruction of pancreatic β-cells. A clinical case of lethal, type 1, fulminant diabetes mellitus is presented. The patient management strategy and possible causes of the adverse course and outcome of the disease are analyzed.
全文:

作者简介
T. Saprina
Siberian State Medical University
编辑信件的主要联系方式.
Email: tvsaprina@gmail.com
ORCID iD: 0000-0001-9011-8720
MD, PhD, DSc, Professor
俄罗斯联邦, TomskN. Musina
Siberian State Medical University
Email: nadiezhda-musina@mail.ru
ORCID iD: 0000-0001-7148-6739
俄罗斯联邦, Tomsk
S. Vtorushin
Siberian State Medical University; Cancer Research Institute, Tomsk National Research Medical Center
Email: wtorushin@rambler.ru
ORCID iD: 0000-0002-1195-4008
MD, PhD, DSc, Professor
俄罗斯联邦, TomskN. Krakhmal’
Siberian State Medical University; Cancer Research Institute, Tomsk National Research Medical Center
Email: krakhmal@mail.ru
ORCID iD: 0000-0002-1909-1681
MD, PhD
俄罗斯联邦, TomskYu. Rogovskaya
Cardiology Research Institute, Tomsk National Research Medical Center
Email: mynga@sibmail.com
ORCID iD: 0000-0001-5553-7831
MD, PhD
俄罗斯联邦, Tomsk参考
- Imagawa A., Hanafusa T., Miyagawa J., Matsuzawa Y. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM Study Group. N. Engl. J. Med. 2000; 342(5): 301–7. doi: 10.1056/NEJM200002033420501.
- Moreau C., Drui D., Arnault-Ouary G., Charbonnel B., Chaillous L., Cariou B. Fulminant type 1 diabetes in Caucasians: a report of three cases. Diabetes Metab. 2008; 34(5): 529–32. doi: 10.1016/j.diabet.2008.05.003.
- Imagawa A., Hanafusa T., Uchigata Y., Kanatsuka A., Kawasaki E., Kobayashi T. et al. Fulminant type 1 diabetes: a nationwide survey in Japan. Diabetes Care. 2003; 26(8): 2345–52. doi: 10.2337/diacare.26.8.2345.
- Imagawa A., Hanafusa T. Pathogenesis of fulminant type 1 diabetes. Rev Diabet Stud. 2006; 3(4): 169–77. doi: 10.1900/RDS.2006.3.169.
- Imagawa A., Hanafusa T., Makino H., Miyagawa J.I., Juto P. High titres of IgA antibodies to enterovirus in fulminant type-1 diabetes. Diabetologia. 2005 Feb; 48(2): 290–3. doi: 10.1007/s00125-004-1624-z.
- Tanaka S., Nishida Y., Aida K., Maruyama T., Shimada A., Suzuki M. et al. Enterovirus infection, CXC chemokine ligand 10 (CXCL10), and CXCR3 circuit: a mechanism of accelerated beta-cell failure in fulminant type 1 diabetes. Diabetes. 2009; 58(10): 2285–91. doi: 10.2337/db09-0091.
- Imagawa A., Hanafusa T., Awata T., Ikegami H., Uchigata Y., Osawa H. et al. Report of the Committee of the Japan Diabetes Society on the research of fulminant and acute-onset type 1 diabetes mellitus: new diagnostic criteria of fulminant type 1 diabetes mellitus (2012). Diabetes Investig. 2012; 3(6): 536–9. doi: 10.1111/jdi.12024.
- Uto T., Uto K., Teno S., Isono K., Omori Y. A case of fulminant type 1 diabetes mellitus detected after cardiac arrest due to diabetic ketoacidosis. J Japan Diab Soc. 2002; 45(9): 689–93. doi: 10.11213/tonyobyo1958.45.689.
- Shimizu I., Makino H., Imagawa A., Iwahashi H., Uchigata Y., Kanatsuka A., Clinical and Immunogenetic Characteristics of Fulminant Type 1 Diabetes Associated With Pregnancy. J Clin Endocrinol Metab. 2006; 91(2): 471-6. doi: 10.1210/jc.2005-1943.
补充文件
